Analyst Consensus
- Current Price
- 123.76 $
- Target (Low)
- 122.00 $
- Target (Mean)
- 157.57 $
- Target (High)
- 180.00 $
- Recommendation
- Buy
- Number of Analysts
- 28
Recommendation Distribution
Recommendation Distribution| Strong Buy | 6 |
|---|
| Buy | 17 |
|---|
| Hold | 7 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 31.0%
- Operating Margin
- 39.3%
- Gross Margin
- 79.4%
- Return on Equity (ROE)
- 43.4%
- Return on Assets (ROA)
- 13.3%
- Revenue Growth
- 4.4%
- Earnings Growth
- 54.8%
- Debt/Equity
- 94.64
- Current Ratio
- 1.97
- Beta
- 0.33
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 16, 2026 | Cantor Fitzgerald | Overweight → Overweight |
| May 20, 2026 | Maxim Group | Hold → Buy |
| May 8, 2026 | Truist Securities | Buy → Buy |
| May 8, 2026 | RBC Capital | Sector Perform → Sector Perform |
| Apr 13, 2026 | Citigroup | Buy → Buy |
| Apr 10, 2026 | Morgan Stanley | Overweight → Overweight |